CXCL9 and rheumatoid arthritis: The results of ELISA and transwell assay showed that the activation, migration, and invasion of RA-FLSs were decreased following treatment of miR-320a mimic + oe-NC, which was rescued by treatment of miR-320a mimic + oe-CXCL9 (Figures 5B–F).